Nutrition and cognitive impairment in the elderly

被引:83
作者
González-Gross, M
Marcos, A
Pietrzik, K
机构
[1] Univ Complutense Madrid, Fac Farm, CSIC, Inst Nutr & Bromatol, E-28040 Madrid, Spain
[2] Univ Bonn, Inst Ernahrungswissensch, Abt Pathophysiol Ernahrung, D-53115 Bonn, Germany
关键词
dementia; vitamins; homocysteine; elderly; Alzheimer's disease;
D O I
10.1079/BJN2001388
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
As the number of older people is growing rapidly worldwide and the fact that elderly people are also apparently living longer, dementia, the most common cause of cognitive impairment is getting to be a greater public health problem. Nutrition plays a role in the ageing process, but there is still a lack of knowledge about nutrition-related risk factors in cognitive impairment. Research in this area has been intensive during the last decade, and results indicate that subclinical deficiency in essential nutrients (antioxidants such as vitamins C, E and beta -carotene, vitamin B-12, vitamin B-6, folate) and nutrition-related disorders, as hypercholesterolaemia, hypertriacylglycerolaemia, hypertension, and diabetes could be some of the nutrition-related risk factors, which can be present for a long time before cognitive impairment becomes evident. Large-scale clinical trials in high-risk populations are needed to determine whether lowering blood homocysteine levels reduces the risk of cognitive impairment and may delay the clinical onset of dementia and perhaps of Alzheimer's disease. A curative treatment of cognitive impairment, especially Alzheimer's disease, is currently impossible. Actual drug therapy, if started early enough, may slow down the progression of the disease. Longitudinal studies are required in order to establish the possible link of nutrient intake - nutritional status with cognitive impairment, and if it is possible, in fact, to inhibit or delay the onset of dementia.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 104 条
[61]   Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type [J].
Maurer, K ;
Ihl, R ;
Dierks, T ;
Frolich, L .
JOURNAL OF PSYCHIATRIC RESEARCH, 1997, 31 (06) :645-655
[62]  
McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO
[63]  
2-8
[64]  
Miller JW, 1999, NUTR REV, V57, P126
[65]   Low-density lipoprotein cholesterol and the risk of dementia with stroke [J].
Moroney, JT ;
Tang, MX ;
Berglund, L ;
Small, S ;
Merchant, C ;
Bell, K ;
Stern, Y ;
Mayeux, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :254-260
[66]   Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease [J].
Morris, MC ;
Beckett, LA ;
Scherr, PA ;
Hebert, LE ;
Bennett, DA ;
Field, TS ;
Evans, DA .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (03) :121-126
[67]  
*NATL LIB MED, 1999, MEDL
[68]   Hyperhomocysteinaemia - A common finding in a psychogeriatric population [J].
Nilsson, K ;
Gustafson, L ;
Faldt, R ;
Andersson, A ;
Brattstrom, L ;
Lindgren, A ;
Israelsson, B ;
Hultberg, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) :853-859
[69]  
NORBERG A, 1989, NURS CLIN N AM, V24, P781
[70]   Cohort study of vitamin C intake and cognitive impairment [J].
Paleologos, M ;
Cumming, RG ;
Lazarus, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 148 (01) :45-50